To illustrate this point, STAT3 was reported to be a marker of worse clinical outcome in head and neck cancer as well as breast cancer [15,160,161,162,163], the same types of cancer in which STAT3 was found to be associated with a better clinical outcome in other studies [156,157,159]. The gene discussed is STAT3; the disease is breast carcinoma.